Security key
761330109
Revance Therapeutics, Inc. - Common Stock, par value $0.001 per share (RVNC)
CUSIP: 761330109
Q2 2024 13F Holders as of 30 Jun 2024
- Security type / class
- Equity / Common Stock, par value $0.001 per share
- Total 13F shares
- 81,357,406
- Total 13F value
- $209,091,543
- Share change
- -1,678,380
- Put/Call ratio
- 35%
- SEC-reported price per share
- $2.57
- Number of holders
- 167
- Value change
- -$16,845,100
- Number of buys
- 86
- Number of sells
- 80
- Shares outstanding
- 104,661,494
Holder snapshot
7 signals
Open additional details 1 more signal available
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q2 2024
Institutions
167
Top holders
10
RVNC full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q3 2024
Previous quarter: Q1 2024
Revance Therapeutics, Inc. SEC filings
Revance Therapeutics, Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 761330109
Recent filing periods:
Ownership snapshot
Top reported holders of RVNC - Revance Therapeutics, Inc. - Common Stock, par value $0.001 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
Capital World Investors
Disclosed value leader
Capital World Investors
Comparable rows
15/15
Latest evidence
31 Mar 2024
13F
Lead comparable stake: 13%
Showing 1-6 of 15 holder rows.
Quick read
Capital World Investors leads the comparable SEC ownership view at 13%.
15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens Capital World Investors's linked filing trail.
Comparable ownership
Top 5
Capital World Investors
13%
BlackRock Finance, Inc.
7%
FRANKLIN RESOURCES INC
6%
VANGUARD GROUP INC
5.2%
Palo Alto Investors LP
5%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| Capital World Investors |
13F
Company
|
13%
|
$68,612,032
13,945,535 shares
|
— | 31 Mar 2024 |
| BlackRock Finance, Inc. |
13F
Company
|
7%
|
$35,977,397
7,312,479 shares
|
— | 31 Mar 2024 |
| FRANKLIN RESOURCES INC |
13F
Company
|
6%
|
$30,914,364
6,283,407 shares
|
— | 31 Mar 2024 |
| VANGUARD GROUP INC |
13F
Company
|
5.2%
|
$26,560,157
5,398,406 shares
|
— | 31 Mar 2024 |
| Palo Alto Investors LP |
13F
Company
|
5%
|
$25,820,180
5,248,004 shares
|
— | 31 Mar 2024 |
| Polar Capital Holdings Plc |
13F
Company
|
3.7%
|
$19,113,309
3,884,819 shares
|
— | 31 Mar 2024 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q2 2024
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
167
Shares
81,357,406
Rows available
167
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q2 2024 vs Q1 2024 Across Filers
Q1 2024 holders
182
Q2 2024 holders
167
Holder diff
-15
| Investor | Q1 2024 Shares | Q2 2024 Shares | Share Diff | Share Chg % | Q1 2024 value | Q2 2024 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend